An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Several experts said the demand for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.
Service Response and Material Removal
Based on the social media company, the service has taken down violative content and banned related keywords and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, positive reviews and detailed instructions for preparing or injecting at home.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Product Information and Pricing
Within these groups, posts show dark colored packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious health risks”.
